脑部放疗,上午比下午敏感许多!# n0 R. A1 D: d6 y3 V# p$ u! N
% M' ?) Q/ p9 @4 R1 |2 ^( R
8 a2 g1 R; `" f3 y" p! U" _, P
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
3 G3 P- H! x* }Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?4 j* q: n- O1 h V6 l6 P2 f5 P$ C' W
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
/ g3 H" {5 w4 i% Y# h0 VSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
2 @0 M8 D+ _/ ]/ @8 A9 k- K7 U0 M" z: V" M( v1 _
Abstract- v7 k- \4 _& v+ z4 M
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.' H4 u+ V' M3 |# w0 \. B
8 J; n$ w+ f2 R6 K8 H# ^6 `METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.2 I, {6 o" ]" Q. p& p/ q$ K" r
. o' P5 |- B# }, @) G4 f' kRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
6 Z2 G# Z) D% p* m' F, S
# U3 j' E& z( E. ^- o5 p3 ]CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.# y9 m) V1 Z+ D3 Y9 K1 E
! `! l5 J. d* s* O |